Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer.
D000236:Adenoma / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000378:metabolism; D002277:Carcinoma / Q000378:metabolism; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism*; D015179:Colorectal Neoplasms / Q000378:metabolism*; D003593:Cytoplasm / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D018450:Disease Progression; D006801:Humans; D007150:Immunohistochemistry; D009362:Neoplasm Metastasis; D011379:Prognosis; D015534:Trans-Activators / Q000378:metabolism*; D016896:Treatment Outcome; D051176:beta Catenin
D000911:Antibodies, Monoclonal; C495270:CTNNB1 protein, human; D003598:Cytoskeletal Proteins; D015534:Trans-Activators; D051176:beta Catenin